Skip to content
healthcare.dev

OGIVRI

NDC 67457-847, trastuzumab, kit, from Mylan Institutional LLC.

Product NDC
67457-847
Status
Listed
Labeler
Mylan Institutional LLC
Dosage form
KIT
Route
—
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761074
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67457-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
67457-847-44674570847441 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6b7938e6-14c7-4a65-9605-967542ecfb8f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67457-847

Use it

Look up 67457-847 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67457-847 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67457-847. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.